Начало・Списък с акции・Progyny Inc

Progyny Inc

Затворен

СекторЗдравеопазване

31.63 0.7

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

31.29

Максимум

31.68

Ключови измерители
By Trading Economics
Приходи	12M 24M
Продажби	10M 329M
P/E Средно за сектора	40.429 68.51
EPS	0.5
Марж на печалбата	7.376
Служители	835
EBITDA	19M 38M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+6.25% upside

Дивиденти
By Acuity
Следващи печалби	6.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	890M 2.4B
Предишно отваряне	30.93
Предишно затваряне	31.63

Настроения в новините

By Acuity

23%

77%

81 / 340 Класиране в Healthcare

Progyny Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.07.2026 г., 19:46 ч. UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30.07.2026 г., 21:02 ч. UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29.07.2026 г., 18:55 ч. UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28.07.2026 г., 17:41 ч. UTC

News

Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24.07.2026 г., 15:06 ч. UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22.07.2026 г., 20:01 ч. UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20.07.2026 г., 17:16 ч. UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Сравнение с други в отрасъла

Ценова промяна

Progyny Inc Прогноза

Ценова цел

By TipRanks

6.25% нагоре

12-месечна прогноза

Среден 33.5 USD 6.25%

Висок 40 USD

Нисък 27 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Progyny Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

10 ratings

Купи

Задържане

Продай

Според 10 анализатори, дали борсови рейтинги на Progyny Inc през последните 3 месеца.

Настроение

By Acuity

81 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.